BRCA2 and breast cancer: Finally, we sought to define whether PALB2-associated breast cancers with bi-allelic PALB2 inactivation would differ from breast cancers arising in BRCA1 and BRCA2 pathogenic germline mutation carriers with bi-allelic inactivation of BRCA1 and BRCA2, respectively.